As controversy swirls over the use of pharmaceutical coupons, Pfizer (PFE) has agreed to pay $975,000 to settle charges of misleading people who wound up spending much more than expected when they used coupons supplied by the drug maker.

This marked the second time in recent months that Pfizer took such a step. Last October, the company reached a $700,000 settlement with New York State over similar allegations.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy